RainTree offers a turnkey process that quickly and effectively determines if a new center is feasible, to include guidance of the Stark Regulatory business structure, and streamlines the development process for a rapid launch. RainTree’s partners combined experience prior to forming RainTree spans more than two decades with 20+ radiation oncology centers, revenues of $120M per year, $100M financed, and $30M in equity raised. Our process is proven with an unparalleled track record of success.